Home > Insider Trading > Filing (0001225208-14-018085)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
9892	Bard C R Inc	BCR	Surgical & Medical Instruments & Apparatus (3841)	221454160

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1204669	K Bronwen Kelly	C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974	Vp - Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-08-04	10,055	$83.47	31,910	No	4	M	Direct
Common Stock	Disposition	2014-08-04	10,055	$150.25	21,855	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (Right to Buy)	Disposition	2014-08-04	10,055	$0.00	10,055	$83.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2017-07-11	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	565	Indirect	401(k) Plan

Footnotes

Includes 7.7878 shares acquired under the Company's Dividend Reinvestment Plan from February 11, 2014 to May 9, 2014.
Represents the weighted average sales price for price increments ranging from $150.17 to $150.535. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.
Includes 1.158 shares acquired under the Company's 401(k) Plan from February 11, 2014 to August 1, 2014.
Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Also granted in tandem with these options were Limited Stock Appreciation Rights which can only be exercised upon a "Change of Control" as defined in the Plan. The LSARs related to the options exercised in this transactions were terminated upon exercise.
Options fully vested in accordance with schedule upon achievement of certain performance criteria.